


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.09%
+0.06%
+1.28%
+105.41%
-3.92%
CRBP
Corbus Pharmaceuticals Ho
$11.07
Strengths

Upgraded on attractively valued

Outperform the market
Chart
$19.1 (-42.04%)
$9.71 (+14.01%)
$8.67 (+27.68%)
$10.15 (+9.06%)
CRBP has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

CRBP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Outperform the market
![]()
CRBP Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CRBP Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is CRBP current stock price?
What are CRBP stock strengths?
What risks are associated with CRBP stock?
When is CRBP next earnings report?
What is CRBP market cap and volume?
What is CRBP's current Stock IQ?
Should I buy CRBP stock right now?
Is CRBP a Strong Buy right now?
What does a 'Strong Buy' rating mean for CRBP?
What does a 'Strong Sell' rating mean for CRBP?
What factors influence CRBP's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.09%
+0.06%
+1.28%
+105.41%
-3.92%
CRBP
Corbus Pharmaceuticals Ho
Current Price
$11.07
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market

Chart
$19.1 (-42.04%)
$9.71 (+14.01%)
$8.67 (+27.68%)
$10.15 (+9.06%)
CRBP Analysts Opinion
CRBP Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Outperform the market
![]()
CRBP Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CRBP Street Sentiment is bullish and have negative views on the near-term outlook
CRBP has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels.
CRBP Latest Analysis
RBC Capital Maintains Corbus Pharmaceuticals Holdings (CRBP) Outperform Recommendation. Fintel reports that on November 13 2025 RBC Capital maintained coverage of Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) with a Outperform recommendation. Analyst Price Forecast Suggests 298.97% Upside
Today
Corbus Pharmaceuticals GAAP EPS of -$1.90 misses by $0.16.
Wed Nov 12, 2025
Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window.
Fri Oct 31, 2025
Corbus Pharmaceuticals Announces Pricing of Public Offering. ) (Corbus or the Company) an oncology and obesity company today announced the pricing of an underwritten public offering of 4744231 shares of its common stock at a public offering price of $13.00 per share and in lieu of common stock to certain investors pre-funded warrants to purchase 1025000 shares of its common stock at a public offering price of $12.9999 per pre-funded warrant for a total public offering size of approximately $75 m
Fri Oct 31, 2025
Corbus Pharmaceuticals announces proposed public offering to fund clinical pipeline.
Thu Oct 30, 2025
Corbus Pharmaceuticals Announces Proposed Public Offering.
Thu Oct 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CRBP Stock trends
CRBP Stock performance
CRBP Stock analysis
CRBP investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.